ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: Insulet

Diabetes’ artificial pancreas still faces a long, bumpy road

Diabetes’ artificial pancreas still faces a long, bumpy road

November 9, 2011 12:40 pm by | 0 Comments

As Medtronic prepares to begin the first U.S. trial of a low-glucose suspense system, and as diabetes device companies, researchers and advocates look to the U.S. Food and Drug Administration ... Read more
Insulet’s Morningstar rating improves, but Medtronic competition looms

Insulet’s Morningstar rating improves, but Medtronic competition looms

July 6, 2011 11:12 am by | 0 Comments

Morningstar analysts upgraded Insulet Corp.’s (NSDQ:PODD) credit rating from a CCC to a B- today, reflecting the company’s recent convertible debt offering, but the company will have to face off ... Read more
Insulet seeks FDA approval for smaller, lighter insulin pump

Insulet seeks FDA approval for smaller, lighter insulin pump

May 10, 2011 4:17 pm by | 1 Comments

Insulet Corp. (NSDQ:PODD) is hoping to win 510(k) clearance for a new Omnipod officials said will help the company reduce its production costs by more than a third.The latest version ... Read more